All I want to talk about and all I care about goin
Post# of 36537
(Total Views: 172)
Posted On: 08/19/2020 9:05:29 AM
All I want to talk about and all I care about going forward is what is in the best interest of the shareholders, new investors and both companies.
Yesterday was a vast improvement over what we have seen lately.
Last night wasn’t.
Yesterday we saw news come out that showed potential for NGIO to make profit. Lots of profit and in return, Generex would as well since they own the majority of the stock in NGIO.
It’s imperative that the S-1 gets filed now for NGIO and they get listed. It’s imperative that we hear something on the peptides.
This is when we now need to start hearing the other news. Yesterday was the opening of the floodgates for all the other news to start coming out.
We need to hear positive things. We do not need to be discussing a ceo who flies off the handle and attacks his shareholders nastily. When the discussion is about the ceo and how he acts, there’s a problem there that might need to be addressed eventually as well.
Joe needs to concentrate on getting the companies to be successful. If he is more concerned with attacking shareholders the way he is, maybe he is not the right ceo. That’s another topic to discuss at a shareholder meeting.
I want Generex and NGIO to succeed. They look to be very close. Let’s hope management pulls it through.
Yesterday was a vast improvement over what we have seen lately.
Last night wasn’t.
Yesterday we saw news come out that showed potential for NGIO to make profit. Lots of profit and in return, Generex would as well since they own the majority of the stock in NGIO.
It’s imperative that the S-1 gets filed now for NGIO and they get listed. It’s imperative that we hear something on the peptides.
This is when we now need to start hearing the other news. Yesterday was the opening of the floodgates for all the other news to start coming out.
We need to hear positive things. We do not need to be discussing a ceo who flies off the handle and attacks his shareholders nastily. When the discussion is about the ceo and how he acts, there’s a problem there that might need to be addressed eventually as well.
Joe needs to concentrate on getting the companies to be successful. If he is more concerned with attacking shareholders the way he is, maybe he is not the right ceo. That’s another topic to discuss at a shareholder meeting.
I want Generex and NGIO to succeed. They look to be very close. Let’s hope management pulls it through.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼